Grupo de Apoio ao Adolescente e a Crianca com Cancer Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT02273583
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

cyclophosphamide (cytoxan) (2 trials)

methotrexate (1 trial)

naltrexone (revia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteosarcoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3